Chandler Robinson - Mar 4, 2025 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role: Chief Executive Officer, Director
Signature: /s/ Quan Vu, Attorney-in-fact
Stock symbol: MNPR
Transactions as of: Mar 4, 2025
Transactions value $: -$55,760
Form type: 4
Date filed: 3/7/2025, 09:24 PM
Previous filing: Jan 2, 2025
Next filing: Apr 2, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MNPR	Common Stock	Options Exercise		+6K	+10.2%		64.9K	Mar 4, 2025	Direct	F1
transaction	MNPR	Common Stock	Tax liability	-$55.8K	-1.76K	-2.71%	$31.70	63.1K	Mar 4, 2025	Direct	F2
holding	MNPR	Common Stock						856K	Mar 4, 2025	See Footnote	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MNPR	Stock Options	Award	$0	+85.8K		$0.00	85.8K	Mar 4, 2025	Common Stock	85.8K	$31.70	Direct	F3
transaction	MNPR	Restricted Stock Units	Award	$0	+79.9K	+321.16%	$0.00	105K	Mar 4, 2025	Common Stock	79.9K	$0.00	Direct	F4
transaction	MNPR	Restricted Stock Units	Options Exercise	$0	-6K	-5.73%	$0.00	98.8K	Mar 4, 2025	Common Stock	6K		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares acquired on vesting and settlement of restricted stock units.
F2	Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
F3	6,647 options vested on the grant date. Remainder of options vest 6/48ths on June 30, 2025, and 1/48th per month thereafter.
F4	6,002 restricted stock units vested on the grant date. Remainder of restricted stock units vest 6/48ths on June 30, 2025, and 3/48ths per quarter thereafter.
F5	As a manager of Tactic Pharma LLC, Dr. Robinson may be deemed to share voting and dispositive power over these 855,589 shares. Dr. Robinson disclaims beneficial ownership of the 855,589 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein.
F6	Represents vesting of 6,002 restricted stock units on the grant date. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.